Mesenchymal regenerative medicines for cartilage regeneration in osteoarthritis
Osteoarthritis (OA) is a slowly progressive disease where cartilage of the synovial joint degenerates. It is most common in the elderly where patients experience pain and reduce physical activity. In combination with lack of conventional treatment, patients are often left with no other choices than arthroplasty. Over the last years, multipotent stromal cells have been used in efforts to treat OA. Mesenchymal stem/progenitor cells (MSCs) are stromal cells that can differentiate into bone, fat, and cartilage cells. They reside within bone marrow and fat.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605352/
Baldur Kristjánsson and Sittisak Honsawek